VaxIQ/mRNA-COVID-19

mRNA-COVID-19

mRNA COVID-19 Vaccine (BNT162b2/mRNA-1273)

Tier 1 · EPI/CoreVaccineCuration in progress

Platform: mRNA lipid nanoparticle

mRNA vaccine that protects against COVID-19 caused by SARS-CoV-2, including severe disease and hospitalization.

mRNAspike proteinCOVID-19metabolomicsIMPACC

PubMed References

PMID 34477808 ↗Klein et al. Adverse events COVID-19 mRNA vaccination. JAMA 2021.

PMID 41410771 ↗Petrova/Diray-Arce. MTHFR predicts COVID severity. PNAS 2025.

Immunology Sections

◷

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Verified References

PMID 34477808 ↗Klein et al. Adverse events COVID-19 mRNA vaccination. JAMA 2021.

PMID 41410771 ↗Petrova/Diray-Arce. MTHFR predicts COVID severity. PNAS 2025.

Wikipedia Overview

Full article ↗

A COVID‑19 vaccine is designed to induce immunity against SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19). COVID-19 vaccines help reduce the risk of severe illness, hospitalisation and death from the virus.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.